Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment

被引：0
|
作者：
Chun-Yong Sun
Le-Le Yang
Pan Zhao
Pei-Zheng Yan
Jia Li
Dong-Sheng Zhao
机构：
[1] Shandong University of Traditional Chinese Medicine,College of Pharmacy
[2] Institute of Chinese Medical Sciences,State Key Laboratory of Quality Research in Chinese Medicine
[3] University of Macau,undefined
来源：
Hereditas | / 159卷
关键词：
Cynarine; Non-alcoholic fatty liver disease; Network pharmacology; Integration analysis; Molecular docking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations
    Xu, Shan
    Tang, Lidan
    Qian, Xiaodan
    Wang, Yujie
    Gong, Jinhong
    Yang, Hao
    Su, Dan
    JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (12)
  • [22] Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
    Day, Kaitlin
    Seale, Lucia A.
    Graham, Ross M.
    Cardoso, Barbara R.
    FRONTIERS IN NUTRITION, 2021, 8
  • [23] Molecular genetics of non-alcoholic fatty liver disease
    Shi, Ivy
    Sakaguchi, Takuya
    CANCER RESEARCH, 2012, 72
  • [24] Molecular pathways in non-alcoholic fatty liver disease
    Berlanga, Alba
    Guiu-Jurado, Esther
    Antonio Porras, Jose
    Auguet, Teresa
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 221 - 238
  • [25] Network Pharmacology Research and Preliminary Verification of Gegen Qinlian Decoction for the Treatment of Non-Alcoholic Fatty Liver Disease
    Hao, Pengfei
    Xiong, Yiyi
    Wu, Hezhen
    Yang, Yanfang
    NATURAL PRODUCT COMMUNICATIONS, 2020, 15 (05)
  • [26] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [27] Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease
    Leamy, Alexandra K.
    Egnatchik, Robert A.
    Young, Jamey D.
    PROGRESS IN LIPID RESEARCH, 2013, 52 (01) : 165 - 174
  • [28] Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease
    Zhang, Meng
    Yuan, Yuan
    Zhou, Wenjing
    Qin, Yali
    Xu, Kaixia
    Men, Jiuzhang
    Lin, Mingxin
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2020, 86
  • [29] Current treatment of non-alcoholic fatty liver disease
    Ahmed, Mohamed H.
    Byrne, Christopher D.
    DIABETES OBESITY & METABOLISM, 2009, 11 (03): : 188 - 195
  • [30] Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
    Francque, Sven
    Vonghia, Luisa
    ADVANCES IN THERAPY, 2019, 36 (05) : 1052 - 1074
12345